BEVERLY HILLS, Calif., Nov. 16, 2010 /PRNewswire-FirstCall/ -- OXIS International, Inc., (OTC Bulletin Board: OXIS; Paris: OXI) today announced that Anthony Cataldo, chief executive officer, and Bernie Landes, president, are scheduled to make an investor presentation at the 3rd Annual LD Micro Conference in Los Angeles on Thursday, December 9, 2010 at 2:00 p.m. Pacific time.  The conference is being held at the Luxe Sunset Boulevard Hotel.

President of LD MICRO, Chris Lahiji stated, "We are very pleased that a local company with fantastic growth potential chose to present at our event. We are excited to learn more about their unique story."

About LD MICRO

LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor.

For more information on the list of presenting companies or to register for the event, please visit http://www.ldmicro.com or call (408) 457-1042.

About OXIS International, Inc.

OXIS International, Inc. develops technologies and products to research, diagnose, treat and prevent diseases of oxidative stress/inflammation associated with damage from free radical and reactive oxygen species (ROS). The company holds the rights to several therapeutic classes of compounds in the area of oxidative stress, and has focused commercialization programs that include SOD (superoxide dismutase), MPO (myeloperoxidase), GPx (glutathione peroxidase), as well as a highly potent antioxidant, Ergothioneine, that may be sold over-the-counter (OTC) as a dietary supplement. Ergothioneine can also be sold to the cosmetics markets as well as the functional food and beverage markets.

SOURCE OXIS International, Inc.